Markets TLX

Telix Opens First Cyclotron Facility In Asia-Pacific

November 21, 2025 — 01:05 am EST

Written by RTTNews.com for RTTNews

(RTTNews) - Telix Pharmaceuticals Ltd. (TLX, TLPPF, TLX.AX), on Friday announced officially opened Telix Manufacturing Solutions in Yokohama, marking its first cyclotron facility in the Asia-Pacific region.

The site will first support clinical supply of TLX250-CDx, Telix's kidney cancer imaging candidate.

Yokohama Telix will later supply other investigational and future commercial radiopharmaceuticals for the treatment of prostate and brain cancer.

Telix Manufacturing Solutions is a 39-site network enabling Telix to produce and distribute radiopharmaceuticals worldwide, supported by major hubs in Brussels and the U.S. and powered by the company's QIS isotope production technology.

Telix Pharma closed trading 0.72% lesser at AUD 13.78 on the Australian Securities Exchange.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Markets
Stocks Mentioned
TLX

Latest Articles
Data is currently not available